Interview

Investing for performance – with purpose at its core

Christoph Wolfensberger is Portfolio Manager of the Robeco Global SDG Equities strategy. Here he talks about his background in finance and the strategy’s approach to bridging its dual objective: aligning investments with the UN SDGs while delivering attractive returns.

Authors

    Portfolio Manager
    James Campbell
    Investment writer

Top keywords

Summary

  1. Macro turmoil is creating opportunities through mispricing
  2. Global SDG Equities strategy aims to balance exposure to growth trends with owning solid, resilient businesses
  3. Focusing on SDGs promotes investing for performance – with purpose at its core

What originally got you into investing?

“I first got into investing back when I was an intern, curious to explore what was possible in finance. I liked working with numbers, building models, and taking a research-driven approach to understanding how outcomes might play out. At the time, I saw it as this exciting world where, if you did your homework right, the possibilities were endless.

I quickly learned it could just as easily become your nightmare – because the market doesn’t always agree with your spreadsheet even if you are quite convinced it should. But that balance of challenge and opportunity is what hooked me. It kept me on my toes and made the job feel less like work and more like a never-ending escape room I actually enjoy getting stuck in every day.”

What makes a good stock?

“Well, the simplest answer is: a good stock is one that goes up – and one that fits within your investment restrictions, of course. But in practice, with our bottom-up approach, a ‘good stock’ is one where the fundamentals, valuation, and long-term prospects line up – where the odds are in your favor. At the end of the day, I think investing is very much a probability game, and the market will test your patience over and over again. And we all know, that you’ll be wrong almost half the time, if you’re lucky.

That’s why a good stock is also one that aligns with your investment thesis – something you feel comfortable buying, scaling into, but also trimming or selling when the time is right or your thesis wrong. The key is knowing what drives the business and being able to incorporate that understanding into your decisions. And, of course, it should offer substantial room for future value creation that the market hasn’t yet fully recognized.”

What’s your biggest lesson learned over the years?

“I’d say one of the biggest lessons is that the market can be absolutely brutal – and it has a way of humbling you the moment you become too convinced of your own view. Much easier said than done, but it’s about trying not to forecast the market and instead focusing on where we can truly add value: finding high-quality businesses with a competitive edge, strong fundamentals, and buying them without overpaying.”

How do you see global markets at the moment?

“Right now, I’d describe global markets as somewhat out of control – driven far more by macro dynamics than by company fundamentals. Politics in particular seems to have an outsized influence, and that adds layers of uncertainty that make investment decisions more complex than they used to be. In many ways, markets feel less about rational pricing and more about reacting to headlines, central bank decisions, or geopolitical events. That doesn’t mean opportunities aren’t there. The large swings we see – sometimes seemingly disconnected from fundamentals – highlight that markets aren’t always efficient. For an active manager, that inefficiency is where the value lies: by doing deep, bottom-up research, identifying high-quality businesses, and understanding the real drivers behind them, you can take advantage of mispricing that short-term, headline-driven trading often creates.”

The market will test your patience again and again Christoph Wolfensberger
Christoph Wolfensberger
Portfolio Manager

Which trends and opportunities are prominent in your strategy?

“On the trend side, the AI theme is clearly and unsurprisingly the most prominent in our strategy. We’re particularly exposed on the infrastructure side, through the businesses the strategy owns, which positions us well to benefit from the ongoing growth in this area. That said, the strategy aims to balance growth stories with more stable assets, and I believe this is where the largest opportunities lie. History shows that every cycle – no matter how long or strong – eventually reaches a point where growth slows, overcapacities appear, and profitability reverts. By combining exposure to exciting growth trends like AI with solid, resilient businesses, we position the portfolio to capture upside while managing the risks that come with cyclical shifts.”

Which are the main differences with the Global Stars strategy?

“Both Global Stars Equities and Global SDG Equities strategies are managed by Robeco’s global fundamental equity team, sharing a high-conviction, bottom-up investment philosophy and a focus on quality companies with integrated sustainability research. Robeco’s Global Stars Equities strategy is Article 8 under SFDR, and explicitly integrates sustainability into its investment decision making, investing within a robust sustainability framework. It has one objective, to generate financial outperformance versus its benchmark over time. Robeco’s Global SDG Equities strategy is the only diversified Article 9 strategy across Robeco’s fundamental global platform that fits into a traditional core allocation. However, it has dual objectives: delivering attractive long-term returns and making a positive, measurable contribution to UN SDGs. The strategy applies Robeco’s SDG Framework to select only companies with a positive SDG score, narrowing the investment universe to those clearly aligned with the UN SDGs.”

Global SDG Equities D USD

performance ytd (30-9)
12.24%
Performance 3y (30-9)
17.59%
morningstar (30-9)
3 / 5
234
SFDR (30-9)
Article 9
Dividend Paying (30-9)
No
View the fund
Past performance is no guarantee of future results. The value of the investments may fluctuate. Annualized (for periods longer than one year). Performances are net of fees and based on transaction prices.

Which positive effects do the SDGs bring to the strategy?

“Focusing on the SDGs brings several positive effects to a portfolio. It makes the strategy highly attractive to investors seeking a dual objective: generating attractive financial returns while supporting positive social and environmental outcomes. By prioritizing companies that are aligned with the SDGs and avoiding those with unethical or unsustainable practices, the strategy reinforces responsible investing principles. From a regulatory point of view, the SDGs are becoming more and more relevant. They enable to measure progress over time and can be applied across the majority of asset classes.”

What’s been your best investment ever?

“It really depends on the time horizon and, of course, the magic of compounding. If we set aside mega-cap index names (which, let’s be honest, have delivered some jaw-dropping returns and may even feature in our Global SDG Equities strategy), and since cherry picking is the name of the game, I’d highlight two favorites*: Builders FirstSource, a manufacturer and distributor of building products, was among my best investments over a three-year stretch. We started building our position in early 2022, when the market was convinced a housing crash was imminent and sentiment was at rock bottom. Our view was different: we saw a structural housing undersupply, strong demographic tailwinds, and migration to low-tax states as powerful offsets. Builders FirstSource’s dominant market position, improving returns on capital, and clear M&A strategy fueled strong growth and cash flow. As the market rebounded in 2023, our conviction paid off – the stock nearly tripled at its peak.

The other, though more short-term, was Medpace, a Contract Research Organization (CRO) providing outsourced clinical development services. It traded at a very depressed valuation due to cyclical and structural CRO headwinds and weak healthcare sentiment. We concluded that its differentiated full-service model and focus on small to mid-sized biopharma clients make it less exposed to large pharma outsourcing shifts positioning it well for a rebound in biotech funding. Further, Medpace’s profitability, cash flow, disciplined financial management, and a large share buyback program supporting EPS growth made it an attractive candidate for inclusion. Call it luck or skill, but just weeks after we added the name to the strategy, the stock jumped over 50% on results day.”

*These are not buy, sell, or hold recommendations. Holdings are subject to change and shown for illustrative purposes only to demonstrate the strategy as of the stated date. Future inclusion of these securities in the strategy is not guaranteed, nor can their future performance be predicted.
This interview was originally published in the Robeco Fundamental Equity Quarterly.


Get the latest insights

Subscribe to our newsletter for investment updates and expert analysis.

Don’t miss out

Let's keep the conversation going

Keep track of fast-moving events in sustainable and quantitative investing, trends and credits with our newsletters.

Don’t miss out

Robeco aims to enable its clients to achieve their financial and sustainability goals by providing superior investment returns and solutions.

Important information
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor.


Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States. This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.